Literature DB >> 26767517

Nanoparticulate mediated transcutaneous immunization: Myth or reality.

Monika Kaurav1, Sunita Minz2, Kantrol Sahu3, Manoj Kumar4, Jitender Madan5, Ravi Shankar Pandey6.   

Abstract

Transcutaneous immunization (TCI) is a promising route of vaccine delivery through skin due to many well documented advantages. The main obstacle in TCI is the skin's top dead layer i.e. stratum corneum which is difficult to penetrate. Efficiently delivery of antigen to the immune competent cells of epidermis or dermis in TCI might elicit an effective immune response. In this review, skin immunology with a particular focus on potential of immunological active receptors in influencing adaptive immune responses is highlighted. The challenges with TCI and methods to improve it using different adjuvants, chemical and physical approaches, delivery systems, and combination of above methods to further improve immune response following skin application of antigen are elaborately discussed. Nanoparticulate vaccine delivery systems with reference to their applications in TCI are classified according to their chronological development. Conclusively, clinical translations of above methods are also briefly reviewed. FROM THE CLINICAL EDITOR: Transcutaneous immunization has been investigated by many as a promising route of vaccination. In this comprehensive review article, the authors described and discussed the existing knowledge and difficulties in this approach. Furthermore, ways of improving transcutaneous delivery were also reviewed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvants; Nanoparticulate delivery systems; Transcutaneous immunization

Mesh:

Substances:

Year:  2016        PMID: 26767517     DOI: 10.1016/j.nano.2015.12.372

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  7 in total

1.  Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.

Authors:  Emad I Wafa; Sean M Geary; Kathleen A Ross; Jonathan T Goodman; Balaji Narasimhan; Aliasger K Salem
Journal:  Nanomedicine       Date:  2019-07-15       Impact factor: 5.307

2.  Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response.

Authors:  Yingjie Yu; Huan Wang; Beibei Guo; Bingkai Wang; Zhan Wan; Yunchang Zhang; Linhong Sun; Feng Yang
Journal:  Eur J Pharm Biopharm       Date:  2022-06-15       Impact factor: 5.589

Review 3.  Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes.

Authors:  Ulrike Kauscher; Margaret N Holme; Mattias Björnmalm; Molly M Stevens
Journal:  Adv Drug Deliv Rev       Date:  2018-10-25       Impact factor: 15.470

Review 4.  Dissolving Microneedle Patches for Dermal Vaccination.

Authors:  M Leone; J Mönkäre; J A Bouwstra; G Kersten
Journal:  Pharm Res       Date:  2017-07-17       Impact factor: 4.200

Review 5.  Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.

Authors:  Sónia Alexandra Correia Carabineiro
Journal:  Molecules       Date:  2017-05-22       Impact factor: 4.411

6.  Lower-Sized Chitosan Nanocapsules for Transcutaneous Antigen Delivery.

Authors:  Juan I Bussio; Carla Molina-Perea; José Vicente González-Aramundiz
Journal:  Nanomaterials (Basel)       Date:  2018-08-26       Impact factor: 5.076

Review 7.  Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.

Authors:  Lev A Dykman
Journal:  Expert Rev Vaccines       Date:  2020-04-28       Impact factor: 5.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.